ANELLOGY
Dead / Abandoned — Abandoned — failure to respond (as of 14 Jun 2023)
What this means for you
This application is over — abandoned 30 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90525511
- Mark type
- Stylized text
- Filed
- 11 Feb 2021
- Published for opposition
- 19 Jul 2022
- Abandoned
- 30 May 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Product development for others in the field of biotechnology and development of pharmaceuticals and therapeutic agents; research and development of therapeutics related to the discovery, capture, and analysis of data in the field of anelloviruses; providing scientific laboratory services for the discovery, capture, and analysis of data in the field of anelloviruses; providing temporary use of non-downloadable software for the discovery, capture, and analysis of data in the field of anelloviruses
Owner
- Ring Therapeutics, Inc., Cambridge, MA, US
- Ring Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 14 Jun 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 14 Jun 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 14 Jun 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 14 Jun 2023 — ASSIGNED TO EXAMINER
- 29 Nov 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Nov 2022 — NON-FINAL ACTION E-MAILED
- 29 Nov 2022 — SU - NON-FINAL ACTION - WRITTEN
- 29 Nov 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Nov 2022 — NON-FINAL ACTION E-MAILED
- 29 Nov 2022 — SU - NON-FINAL ACTION - WRITTEN
- 21 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Oct 2022 — USE AMENDMENT FILED
- 21 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Oct 2022 — TEAS STATEMENT OF USE RECEIVED
- 13 Sept 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT